Loading…

Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma

Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against va...

Full description

Saved in:
Bibliographic Details
Published in:BMC complementary medicine and therapies 2024-07, Vol.24 (1)
Main Authors: Nittayananta, Wipawee, Srichana, Teerapol, Chuerduangphui, Jureeporn, Hitakomate, Ekarat, Netsomboon, Kesinee
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page
container_title BMC complementary medicine and therapies
container_volume 24
creator Nittayananta, Wipawee
Srichana, Teerapol
Chuerduangphui, Jureeporn
Hitakomate, Ekarat
Netsomboon, Kesinee
description Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma
doi_str_mv 10.1186/s12906-024-04450-0
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A802067248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A802067248</galeid><sourcerecordid>A802067248</sourcerecordid><originalsourceid>FETCH-LOGICAL-g988-463bacbf5dbee09d6724c1678d3eda30f867d2bce4c5b7bbb3e5a4939972c3e53</originalsourceid><addsrcrecordid>eNptkMtqwzAQRUVpoSHND3QlKO1OqR62JC9D6AsC3WRXShg97KjIVmrZ_1-HZpFCmYG5M5x7F4PQLaNLxrR8zIxXVBLKC0KLoqSEXqAZl5ITJRW7PNPXaJHzF6WUCyaUKGfIPae-HSMMIXU41Zjd4w-Ihz18kha6JuUhdHjq1IOB7HHj47S60fqM4ZAOQ8ohn4CI8_cIbRoztj5GbKG3oUst3KCrGmL2i9Oco-3z03b9SjbvL2_r1YY0ldakkMKANXXpjPe0clLxwjKptBPegaC1lspxY31hS6OMMcKXUFSiqhS3kxZzdPcb20D0u9DVaejBtiHb3UpTTo-BeqKW_1BTOd8Gmzpfh-n-x_BwZth7iMM-pzgeX5bPwR8APnZU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Nittayananta, Wipawee ; Srichana, Teerapol ; Chuerduangphui, Jureeporn ; Hitakomate, Ekarat ; Netsomboon, Kesinee</creator><creatorcontrib>Nittayananta, Wipawee ; Srichana, Teerapol ; Chuerduangphui, Jureeporn ; Hitakomate, Ekarat ; Netsomboon, Kesinee</creatorcontrib><description>Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma</description><identifier>ISSN: 2662-7671</identifier><identifier>EISSN: 2662-7671</identifier><identifier>DOI: 10.1186/s12906-024-04450-0</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Alternative medicine ; Antiviral agents ; Apoptosis ; Biological products industry ; Cancer ; Care and treatment ; Ethylenediaminetetraacetic acid ; Health aspects ; Nitric oxide ; Papillomavirus infections ; Prevention ; Squamous cell carcinoma ; Wounds and injuries</subject><ispartof>BMC complementary medicine and therapies, 2024-07, Vol.24 (1)</ispartof><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Nittayananta, Wipawee</creatorcontrib><creatorcontrib>Srichana, Teerapol</creatorcontrib><creatorcontrib>Chuerduangphui, Jureeporn</creatorcontrib><creatorcontrib>Hitakomate, Ekarat</creatorcontrib><creatorcontrib>Netsomboon, Kesinee</creatorcontrib><title>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</title><title>BMC complementary medicine and therapies</title><description>Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma</description><subject>Alternative medicine</subject><subject>Antiviral agents</subject><subject>Apoptosis</subject><subject>Biological products industry</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Ethylenediaminetetraacetic acid</subject><subject>Health aspects</subject><subject>Nitric oxide</subject><subject>Papillomavirus infections</subject><subject>Prevention</subject><subject>Squamous cell carcinoma</subject><subject>Wounds and injuries</subject><issn>2662-7671</issn><issn>2662-7671</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptkMtqwzAQRUVpoSHND3QlKO1OqR62JC9D6AsC3WRXShg97KjIVmrZ_1-HZpFCmYG5M5x7F4PQLaNLxrR8zIxXVBLKC0KLoqSEXqAZl5ITJRW7PNPXaJHzF6WUCyaUKGfIPae-HSMMIXU41Zjd4w-Ihz18kha6JuUhdHjq1IOB7HHj47S60fqM4ZAOQ8ohn4CI8_cIbRoztj5GbKG3oUst3KCrGmL2i9Oco-3z03b9SjbvL2_r1YY0ldakkMKANXXpjPe0clLxwjKptBPegaC1lspxY31hS6OMMcKXUFSiqhS3kxZzdPcb20D0u9DVaejBtiHb3UpTTo-BeqKW_1BTOd8Gmzpfh-n-x_BwZth7iMM-pzgeX5bPwR8APnZU</recordid><startdate>20240720</startdate><enddate>20240720</enddate><creator>Nittayananta, Wipawee</creator><creator>Srichana, Teerapol</creator><creator>Chuerduangphui, Jureeporn</creator><creator>Hitakomate, Ekarat</creator><creator>Netsomboon, Kesinee</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20240720</creationdate><title>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</title><author>Nittayananta, Wipawee ; Srichana, Teerapol ; Chuerduangphui, Jureeporn ; Hitakomate, Ekarat ; Netsomboon, Kesinee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g988-463bacbf5dbee09d6724c1678d3eda30f867d2bce4c5b7bbb3e5a4939972c3e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alternative medicine</topic><topic>Antiviral agents</topic><topic>Apoptosis</topic><topic>Biological products industry</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Ethylenediaminetetraacetic acid</topic><topic>Health aspects</topic><topic>Nitric oxide</topic><topic>Papillomavirus infections</topic><topic>Prevention</topic><topic>Squamous cell carcinoma</topic><topic>Wounds and injuries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nittayananta, Wipawee</creatorcontrib><creatorcontrib>Srichana, Teerapol</creatorcontrib><creatorcontrib>Chuerduangphui, Jureeporn</creatorcontrib><creatorcontrib>Hitakomate, Ekarat</creatorcontrib><creatorcontrib>Netsomboon, Kesinee</creatorcontrib><jtitle>BMC complementary medicine and therapies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nittayananta, Wipawee</au><au>Srichana, Teerapol</au><au>Chuerduangphui, Jureeporn</au><au>Hitakomate, Ekarat</au><au>Netsomboon, Kesinee</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma</atitle><jtitle>BMC complementary medicine and therapies</jtitle><date>2024-07-20</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><issn>2662-7671</issn><eissn>2662-7671</eissn><abstract>Background Plant-derived compounds have chemopreventive properties to be used as alternative medicine. Pericarp of Mangosteen (Garcinia mangostana Linn.), a tropical fruit in Southeast Asia contains a phytochemical [alpha]-mangostin ([alpha]-MG) that demonstrates potent anticancer effects against various types of cancer. [alpha]-MG has been reported to be the most effective agent in human cancer cell lines. The objectives of this study were to develop oral gel formulations containing [alpha]-MG and determine their (1) anticancer activity, (2) anti-HPV-16 and antimicrobial activities, (3) nitric oxide (NO) inhibitory activity, and (4) wound healing effect. Methods Formulations of oral gel containing [alpha]-MG were developed. Anticancer activity on SCC-25 was assessed. Apoptotic induction was determined using flow cytometry technique. Antiviral activity against HPV-16 pseudovirus and antimicrobial activity against S. mutans, P. gingivalis and C. albicans were investigated. NO inhibition was carried out. Fibroblast cell migration was determined by in vitro scratch assay. Results The formulation of 1% [alpha]-MG in orabase gel demonstrated anticancer activity by promoting apoptosis in SCC-25. The induction of apoptotic activity was dose dependent with pronounced effect in late apoptosis. The formulation appeared to reduce cell viability of oral keratinocytes (OKC). At CC.sub.50 it showed an inhibition against HPV-16 pseudovirus infection. The formulation had no antimicrobial activity against S. mutans, P. gingivalis and C. albicans. No significant NO inhibitory activity and wound healing effects were found. Conclusions 1% [alpha]-MG in orabase gel exhibited anticancer activity by inducing apoptosis although low level of cytotoxicity observed in OKC was present. The appropriate carrier for novel nano-particles targeting cancer cells should be further investigated. Keywords: Apoptosis, Oral cancer, [alpha]-mangostin, Oral gel, Oral squamous cell carcinoma</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12906-024-04450-0</doi></addata></record>
fulltext fulltext
identifier ISSN: 2662-7671
ispartof BMC complementary medicine and therapies, 2024-07, Vol.24 (1)
issn 2662-7671
2662-7671
language eng
recordid cdi_gale_infotracmisc_A802067248
source Publicly Available Content Database; PubMed Central
subjects Alternative medicine
Antiviral agents
Apoptosis
Biological products industry
Cancer
Care and treatment
Ethylenediaminetetraacetic acid
Health aspects
Nitric oxide
Papillomavirus infections
Prevention
Squamous cell carcinoma
Wounds and injuries
title Formulation of 1% [alpha]-mangostin in orabase gel induces apoptosis in oral squamous cell carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A29%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20of%201%25%20%5Balpha%5D-mangostin%20in%20orabase%20gel%20induces%20apoptosis%20in%20oral%20squamous%20cell%20carcinoma&rft.jtitle=BMC%20complementary%20medicine%20and%20therapies&rft.au=Nittayananta,%20Wipawee&rft.date=2024-07-20&rft.volume=24&rft.issue=1&rft.issn=2662-7671&rft.eissn=2662-7671&rft_id=info:doi/10.1186/s12906-024-04450-0&rft_dat=%3Cgale%3EA802067248%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g988-463bacbf5dbee09d6724c1678d3eda30f867d2bce4c5b7bbb3e5a4939972c3e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A802067248&rfr_iscdi=true